Insider Transactions Reported by 27 Insiders of Zymeworks Inc.

Symbol
ZYME on Nasdaq
Location
Middletown, DE

Insiders trading volume in the past year

Zymeworks Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
EcoR1 Capital, LLC Director, 10%+ Owner $341,953,624 +$28,581,520 +9.1% 26 Jun 2025
OLEG NODELMAN Director, 10%+ Owner $218,112,518 17 Feb 2025
Redmile Group, LLC 10%+ Owner $30,584,956 13 Oct 2022
Kenneth Galbraith Chair & CEO, Director $8,008,729 -$3,337,971 -29% 12 Jan 2026
Gregory Austin Ciongoli Director $5,934,520 12 Jan 2026
Mark Hollywood EVP & Chief Operating Officer $3,013,602 -$138,762 -4.4% 12 Jan 2026
Paul Andrew Moore Chief Scientific Officer $1,890,573 -$721,457 -28% 12 Jan 2026
Jeffrey T L Smith EVP & Chief Medical Officer $1,396,540 -$475,561 -25% 12 Jan 2026
LEONE D. PATTERSON EVP, Chief Bus & Fin Officer $795,819 06 Jan 2026
Christopher Astle SVP & Chief Financial Officer $409,403 05 Jan 2024
Neil Josephson Chief Medical Officer $294,084 10 Nov 2022
Neil Klompas President & COO $229,258 10 Mar 2023
Robert E. Landry Director 12 Jan 2026
HOLLINGS RENTON Director 07 Dec 2023
Derek John Michael Miller Director 10 Dec 2024
Brian N. Cherry Director 12 Jan 2026
Kelvin Neu Director 12 Jan 2026
Nancy Davidson Director 10 Dec 2024
Neil Gallagher Director 10 Dec 2024
Susan Mahony Director 12 Jan 2026
Natalie Sacks Director 21 Dec 2022
Kenneth J. Hillan Director 07 Dec 2023
Troy Cox Director 10 Dec 2024
Carlos Campoy Director 12 Jan 2026
Scott Platshon Director 22 Feb 2024
Alessandra Cesano Director 12 Jan 2026
Lota S. Zoth Director 21 Dec 2022

Recent Insider Transactions by Companies or Individuals for Zymeworks Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.